Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Randomized Phase II Study of the Efficacy and Safety of Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing as Firt-Line Therapy for Metastatic Renal Cell Cancer (Renal EFFECT Trail)
Rinehart, John
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
3/1/07
→
2/28/10
View all
View less